SCHEMBL3846339

SCHEMBL3846339

Clc1ccc(-c2cc[nH]n2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALPL P05186 10/20 0.49
HSP90AA1 P07900 2/20 0.46
HSP90AB1 P08238 2/20 0.46
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
F7 P08709 1/20 0.44
F3 P13726 1/20 0.44
DYRK1A Q13627 1/20 0.44
LMNA P02545 1/20 0.44
IDO1 P14902 1/20 0.43
AHR P35869 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11624239 0.85 IDO1 (0.56) ALPLKMT2AF7F3DYRK1A
SCHEMBL3367634 0.83 HAO1 (0.45) ALPLHSP90AA1HSP90AB1KMT2ALMNA
SCHEMBL25299734 0.81 F7 (0.37) ALPLKMT2AF7F3DYRK1A
SCHEMBL3846744 0.81 KMO (0.44) ALPLMAPK1F7F3DYRK1A
SCHEMBL4971002 0.80 MAPT (0.36) ALPLHSP90AA1HSP90AB1MAPK1KMT2A
SCHEMBL15079440 0.78 IDO1 (0.58) F7F3DYRK1AIDO1
SCHEMBL31039366 0.78 IDO1 (0.38) MAPK1KMT2AF7F3DYRK1A
SCHEMBL14400038 0.78 IDO1 (0.58) MAPK1F7F3DYRK1AIDO1
SCHEMBL6031031 0.78 IDO1 (0.58) MAPK1KMT2ALMNAIDO1KDM4E
SCHEMBL10700472 0.78 ALDH1A1 (0.35) ALPLF7F3DYRK1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed